Loading...
Immunohistochemical Signature Add Prognostic Value in Patients With Early and Intermediate Hepatocellular Carcinoma Underwent Curative Liver Resection
Hepatocellular carcinoma (HCC) is the third most lethal cancer worldwide; however, accurate prognostic tools are still lacking. We aimed to identify immunohistochemistry (IHC)-based signature as a prognostic classifier to predict recurrence and survival in patients with HCC at Barcelona Clinic Liver...
Na minha lista:
| Udgivet i: | Front Oncol |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Frontiers Media S.A.
2021
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7874098/ https://ncbi.nlm.nih.gov/pubmed/33585243 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2020.616263 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|